Verition Fund Management LLC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q4 2021$295,000
-91.7%
235,000
-91.5%
0.00%
-98.6%
Q1 2020$3,547,000
+15.4%
2,757,000
+37.8%
0.14%
+150.0%
Q4 2019$3,073,000
+348.0%
2,000,000
+300.0%
0.06%
+194.7%
Q3 2019$686,000
-89.3%
500,000
-90.7%
0.02%
-95.9%
Q4 2018$6,419,000
-41.5%
5,366,000
-16.5%
0.46%
+17.0%
Q3 2018$10,968,000
+18.1%
6,425,0000.0%0.39%
-30.7%
Q2 2018$9,289,0006,425,0000.57%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders